Traffic safety meta-analysis of reversible lanes

被引:4
|
作者
Manuel, Aaron [1 ]
de Barros, Alexandre [2 ]
Tay, Richard [3 ]
机构
[1] Castleglenn Consultants, 2460 Lancaster Rd,Suite 200, Ottawa, ON K1B 4S5, Canada
[2] Univ Calgary, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada
[3] RMIT Univ, GPO Box 2476, Melbourne, Vic 3001, Australia
来源
关键词
Reversible lane; Lane reversal; Meta-analysis; Meta-regression; DETECT PUBLICATION BIAS;
D O I
10.1016/j.aap.2020.105751
中图分类号
TB18 [人体工程学];
学科分类号
1201 ;
摘要
A meta-analysis was performed to review the potential effects of reversible lanes on traffic safety. A systematic review resulted in ten U.S studies, with 155 estimates of safety effects, that were selected for inclusion in the analysis. These studies employed either a simple before-after comparison or a cross-sectional comparison methodology. Study results were extracted by transforming the collision rates and frequencies of these studies into a log-odds ratio. The results of the meta-analysis suggest that the odds of a collision occurring are 30.9% higher for roads with reversible lanes when compared to roads without the treatment. The odds of a property-damage-only collision are predicted to be 16.6% higher, and injury collisions are predicted to be 34.9% higher with reversible lanes compared to no-treatment. The odds of a collision occurring during the peak period are expected to be 46.2% higher, while the odds of an off-peak period collision occurring are expected to be 12.8% higher. These results were statistically significant, with the exception of the off-peak period collision result. A meta-regression was performed, which regresses variables related to study type, collision type and operational characteristics of the study locations on the extracted log odds ratio. Peak period operations were positively and significantly correlated with an increase in crashes. Presence of left-turn restrictions and/or delineator/barrier were negatively correlated with crashes, whereas the presence of dynamic traffic control and static traffic control were positively correlated with crashes. Finally, cross sectional studies tend to find greater effects than before-after studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The Fetal Safety of Benzodiazepines: An Updated Meta-analysis
    Enato, Ehijie
    Moretti, Myla
    Koren, Gideon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2011, 33 (01) : 46 - 48
  • [32] Progestogen safety: implications for meta-analysis Reply
    Sotiriadis, A.
    Papatheodorou, S.
    Makrydimas, G.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 40 (04) : 487 - 488
  • [33] Pooling, meta-analysis, and the evaluation of drug safety
    Michel Lièvre
    Michel Cucherat
    Alain Leizorovicz
    Current Controlled Trials in Cardiovascular Medicine, 2002, 3
  • [34] Drug Safety Meta-Analysis: Promises and Pitfalls
    Michael A. Stoto
    Drug Safety, 2015, 38 : 233 - 243
  • [35] Meta-analysis of the Safety and Efficacy of Bempedoic Acid
    Khan, Muhammad U.
    Khan, Muhammad Zia
    Munir, Muhammad Bilal
    Balla, Sudarshan
    Khan, Safi U.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 131 : 130 - 132
  • [36] Safety of nifedipine in angina pectoris - A meta-analysis
    Stason, WB
    Schmid, CH
    Niedzwiecki, D
    Whiting, GW
    Caubet, JF
    Cory, D
    Luo, D
    Ross, SD
    Chalmers, TC
    HYPERTENSION, 1999, 33 (01) : 24 - 31
  • [37] Drug Safety Meta-Analysis: Promises and Pitfalls
    Stoto, Michael A.
    DRUG SAFETY, 2015, 38 (03) : 233 - 243
  • [38] Systematic review and meta-analysis on the safety of dalbavancin
    Monteagudo-Martinez, N.
    Solis-Garcia Del Pozo, J.
    Ikuta, I.
    Galindo, Mf
    Jordan, J.
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (09) : 1095 - 1107
  • [39] Tiotropium formulations and safety: a network meta-analysis
    Cazzola, Mario
    Calzetta, Luigino
    Rogliani, Paola
    Matera, Maria Gabriella
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2017, 8 (01) : 17 - 30
  • [40] Meta-analysis: Efficacy and Safety of Zuranolone for Depression
    Kessing, Richard
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2025, 93 (03) : 76 - 76